MDHearing Volt vs RCA In-Ear

The MDHearing Volt is a budget-priced prescription hearing aid released in 2020, earning a B grade with a SoundScore of 3.0/5 in our lab testing. At $397, it sits in the lowest price tier for prescription devices, ranking #34 of 39 in its category. In our testing, the Volt showed a mixed performance profile with one standout strength: feedback handling scored an excellent 5.0/5, which is 0.28 points above the category average. This means users can expect minimal whistling or squealing during typical wear. However, speech performance was limited, with speech in quiet scoring 1.8/5 (1.65 points below average) and speech in noise at 1.0/5 (1.11 points below average). Own voice comfort was mixed at 2.6/5, roughly matching the category average. Music streaming capability was not functional in our testing, scoring 0.0/5—a significant limitation for users who want to stream audio from their phone. This is 2.76 points below the prescription hearing aid category average. The Volt may appeal to budget-conscious consumers who prioritize basic amplification and feedback-free wear over advanced speech enhancement or streaming features. Those seeking stronger speech performance in the same price range may want to consider alternatives like the RxEars Rxi, which scored 4.07/5 in our testing. The Volt's rechargeable battery and behind-the-ear design offer practical convenience, but its core sound performance reflects its entry-level positioning.

The RCA In-Ear is a budget-priced OTC hearing aid available for $249, earning a C grade with a SoundScore of 2.8/5 in our lab testing. This places it near the bottom of the OTC hearing aid category, ranking 64th out of 65 devices tested. In our standardized testing, the RCA In-Ear shows a mixed performance profile. Its standout strength is excellent feedback handling, scoring a perfect 5.0/5—0.46 points above the category average. This means users are unlikely to experience whistling or squealing during normal wear. Own-voice comfort scores 2.6/5, which is essentially at the category average (+0.09 points), offering mixed but acceptable performance for how your own voice sounds while wearing the devices. However, the core speech performance metrics present significant limitations. Speech in quiet scores just 1.0/5, falling 1.79 points below the category average, and speech in noise also scores 1.0/5, sitting 0.48 points below average. Music streaming scored 0.0/5, indicating this device is not suitable for audio entertainment purposes. At this price point, buyers have considerably stronger options. Competitors like the Lucid Enrich Pro and JLab Hear OTC offer better sound performance at lower prices. The RCA In-Ear may appeal to those prioritizing feedback-free wear above speech clarity, but most users seeking meaningful hearing benefit should consider higher-performing alternatives in this budget segment.